- Home
- BDTX vs PLG Comparison
BDTX vs PLG Comparison
Compare BDTX & PLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | PLG |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.9M | 167.4M |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | BDTX | PLG |
|---|---|---|
| Price | $1.79 | $1.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 888.1K |
| Earning Date | 05-08-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.60 | $1.18 |
| 52 Week High | $4.94 | $4.04 |
Technical Indicators
Market Signals| Indicator | BDTX | PLG |
|---|---|---|
| Relative Strength Index (RSI) | 42.31 | 41.11 |
| Support Level | $1.76 | $1.25 |
| Resistance Level | $2.26 | $1.48 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 6.17 | 39.13 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
About PLG Platinum Group Metals Ltd. (Canada)
Platinum Group Metals Ltd is a development-stage company, conducts work on mineral properties it has staked or acquired by way of option agreements in the Republic of South Africa. Key metals of economic interest on the company's mineral properties include platinum, palladium, rhodium, gold, copper, and nickel. The company operates in one segment, the development of the Waterberg Project in South Africa, and geographically in Canada and South Africa.